“…1,2 In studies comparing FLACS with conventional phacoemulsification, there have been no meaningful differences in vision/refractive outcomes or patient-reported health and safety outcomes. [2][3][4][5] However, studies comparing FLACS with conventional phacoemulsification are limited by the overall rarity of complications in both types of cataract surgery, authors' financial relationships with platform manufacturers, and lack of standardization in reporting complications and visual acuity. 5 Among the possible advantages of FLACS, it has been shown to reduce endothelial cell loss in eyes with shallow anterior chambers, Fuchs dystrophy, and dense cataracts.…”